{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:56:51Z","timestamp":1781233011738,"version":"3.54.1"},"reference-count":33,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Peritoneal metastases from breast cancer (PMBC) are rare, aggressive, and lack standardized management. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a potential locoregional strategy for highly selected patients. This PRISMA-informed narrative review used a structured and reproducible search and study-selection process, SWiM-guided narrative synthesis, and descriptive pooled individual-patient data (IPD) analysis to evaluate the feasibility, safety, and reported oncologic outcomes of CRS plus HIPEC in PMBC. Methods: The English-language literature was searched in PubMed\/MEDLINE, Embase, and Google Scholar up to 31 December 2025. Eligible peer-reviewed full-text articles reported PMBC patients treated with CRS plus HIPEC and at least one perioperative or oncologic outcome. Patient-level data were extracted when explicitly reported and were summarized descriptively; no inferential survival analysis was performed. Risk of bias was assessed using JBI checklists for case reports\/series and ROBINS-I for the multicenter cohort. Results: Six peer-reviewed studies were included (66 PMBC patients); 30 patients underwent CRS plus HIPEC. Five studies provided sufficient patient-level data for descriptive pooled IPD analysis (n = 17). Median age at CRS\/HIPEC was 56 years (n = 13 with reported age), and the median interval between breast cancer diagnosis and PMBC was 12 years (range 0\u201330 years; available-case analysis). Median PCI was 21.5 (n = 16), and complete cytoreduction (CC-0) was achieved in 9 of 17 patients. Major postoperative morbidity occurred in 17.6%, while no in-hospital or 30-day mortality was reported. Reported disease-control and survival outcomes were heterogeneous and are therefore summarized only descriptively. In the multicenter cohort, curative-intent CRS with or without HIPEC was associated with a median overall survival of 61.5 months measured from diagnosis of peritoneal metastases; however, HIPEC-specific baseline characteristics and oncologic outcomes were not separately stratified. Conclusions: CRS plus HIPEC appears feasible in highly selected PMBC patients and may be associated with favorable outcomes when complete cytoreduction is achievable. However, the evidence is sparse, heterogeneous, and highly prone to selection and publication bias. Therefore, no causal inference regarding the independent benefit of HIPEC can be drawn, and this approach should be considered investigational pending prospective multicenter registries.<\/jats:p>","DOI":"10.3390\/jcm15124511","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:50:58Z","timestamp":1781157058000},"page":"4511","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Metastases from Breast Cancer: A Comprehensive Review and Pooled Individual-Patient Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0160-7755","authenticated-orcid":false,"given":"Dimitrios","family":"Papageorgiou","sequence":"first","affiliation":[{"name":"Department of Gynecology, Athens Naval and Veterans Hospital, 11521 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9856-8152","authenticated-orcid":false,"given":"Vasileios","family":"Kalles","sequence":"additional","affiliation":[{"name":"Department of Surgery, Athens Naval and Veterans Hospital, 11521 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4510-1633","authenticated-orcid":false,"given":"Vasilios","family":"Pergialiotis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 10679 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9723-5054","authenticated-orcid":false,"given":"Ioannis K.","family":"Papapanagiotou","sequence":"additional","affiliation":[{"name":"Laboratory of Anatomy, Faculty of Nursing, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-6316","authenticated-orcid":false,"given":"Nikolaos","family":"Tasis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Athens Naval and Veterans Hospital, 11521 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savvas","family":"Petrogiannis","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Athens Naval and Veterans Hospital, 11521 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5712-1191","authenticated-orcid":false,"given":"Katerina","family":"Papakonstantinou","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Athens Naval and Veterans Hospital, 11521 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-0608","authenticated-orcid":false,"given":"Ioakeim","family":"Sapantzoglou","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 10679 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1200\/JOP.2015.008953","article-title":"Curing metastatic breast cancer","volume":"12","author":"Sledge","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s40064-015-1449-x","article-title":"Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer","volume":"4","author":"Bertozzi","year":"2015","journal-title":"SpringerPlus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ejca.2009.04.027","article-title":"Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosis","volume":"45","author":"Tuthill","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_5","first-page":"83","article-title":"Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer","volume":"16","author":"Sugarbaker","year":"1989","journal-title":"Semin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejogrb.2020.05.058","article-title":"Total extraperitoneal access for parietal peritonectomy for peritoneal surface malignancy: The \u201ccocoon\u201d technique","volume":"251","author":"Kyriazanos","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PPO.0b013e3181a9c6f0","article-title":"Surgical techniques in visceral resection and peritonectomy procedures","volume":"15","author":"Bao","year":"2009","journal-title":"Cancer J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","article-title":"Peritonectomy procedures","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12957-015-0703-6","article-title":"Cytoreduction and HIPEC in the treatment of \u201cunconventional\u201d secondary peritoneal carcinomatosis","volume":"13","author":"Cardi","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"Koole","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jso.25642","article-title":"Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases","volume":"120","author":"Kyang","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00404-020-05687-z","article-title":"A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"302","author":"Papageorgiou","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"ref_16","first-page":"2127","article-title":"Methodological quality of case series studies: An introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10353-005-0207-7","article-title":"Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion in the treatment of ovarian and peritoneal metastasis from breast carcinoma\u2014A case report","volume":"38","author":"Erdem","year":"2006","journal-title":"Eur. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.breast.2013.02.020","article-title":"Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and hyperthermic intraperitoneal chemotherapy: A preliminary report on 5 cases","volume":"22","author":"Cardi","year":"2013","journal-title":"Breast"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.21037\/gs-20-893","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis from breast cancer: A preliminary report of 4 cases","volume":"10","author":"Yu","year":"2021","journal-title":"Gland Surg."},{"key":"ref_21","first-page":"1047","article-title":"Breast cancer peritoneal metastasis: Role of cytoreductive surgery and HIPEC","volume":"4","author":"Spiliotis","year":"2021","journal-title":"Ann. Surg. Case Rep."},{"key":"ref_22","first-page":"e38767","article-title":"Achieving intraperitoneal disease control using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Two cases of metastatic breast cancer","volume":"15","author":"Barakat","year":"2023","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cardi, M., Pocard, M., Dico, R.L., Fiorentini, G., Valle, M., Gelmini, R., Vaira, M., Pasqual, E.M., Asero, S., and Baiocchi, G. (2022). Selected patients with peritoneal metastases from breast cancer may benefit from cytoreductive surgery: Results of a multicenter survey. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.822550"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ejso.2018.07.049","article-title":"Peritoneal metastases from extra-abdominal cancer\u2014A population-based study","volume":"44","author":"Flanagan","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chicago Consensus Working Group (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. Ann. Surg. Oncol., 27, 1793\u20131797.","DOI":"10.1245\/s10434-020-08319-7"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/ans.70214","article-title":"Long-term survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei: A 22-year single institution experience","volume":"95","author":"Kaur","year":"2025","journal-title":"ANZ J. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2018.03.015","article-title":"Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort","volume":"96","author":"Gobbini","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.016","article-title":"Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008\u20132016","volume":"129","author":"Deluche","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","article-title":"4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/cncr.29134","article-title":"The rise in metastasectomy across cancer types over the past decade","volume":"121","author":"Bartlett","year":"2015","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ejso.2020.03.214","article-title":"Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes","volume":"46","author":"Chun","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102114","DOI":"10.1016\/j.ctrv.2020.102114","article-title":"Prognostic factors in patients with oligometastatic breast can-cer\u2014A systematic review","volume":"91","author":"Steenbruggen","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s12282-021-01240-1","article-title":"Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: An updated report","volume":"28","author":"Nagasaki","year":"2021","journal-title":"Breast Cancer"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4511\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:15:28Z","timestamp":1781230528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124511"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124511","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}